MediMix Profile
MediMix

@Medi_Mix

Followers
203
Following
118
Statuses
925

MediMix, your communication partner with a focus on quality information in easy consumable formats, tailor-made for medical specialists.

Joined April 2023
Don't wanna be here? Send us removal request.
@Medi_Mix
MediMix
9 hours
๐—•๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—›๐—ถ๐—ด๐—ต๐—น๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ผ๐—ณ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ - ๐—ก๐—ผ๐˜„ ๐—”๐˜ƒ๐—ฎ๐—ถ๐—น๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ผ๐—ป ๐—”๐—ฐ๐—ฐ๐—ฟ๐—ฒ๐—ฑ๐—ถ๐— ๐—ถ๐˜… < โœ… Translational research in breast cancer: what should you not have missed in 2024? โœ… Whatโ€™s new in radiotherapy for breast cancer? โœ… Whatโ€™s new in breast cancer surgery? โœ… Advances in the systemic treatment for early-stage breast cancer โœ… Advances in the systemic treatment for advanced breast cancer Register or log in at ๐Ÿ“Œ This educational content is intended for healthcare professionals. #BreastCancer #Oncology #MedicalEducation #AccrediMix #CancerResearch
Tweet media one
0
0
0
@Medi_Mix
MediMix
1 day
๐ŸšจPoster from #ASCOGI2025! Dr @RonaYaeger reports 43% ORR and 16-month OS for adagrasib + cetuximab in KRASG12C-mutated mCRC. ๐Ÿ”น PFS: 6.9 months ๐Ÿ”น 66% of patients alive at 1 year Watch now! ๐Ÿ‘€#MediMix #CancerResearch #ColorectalCancer
0
1
1
@Medi_Mix
MediMix
1 day
0
0
0
@Medi_Mix
MediMix
1 day
0
0
0
@Medi_Mix
MediMix
2 days
0
0
0
@Medi_Mix
MediMix
2 days
๐Ÿ“บ Register or log in at ๐Ÿ“Œ This educational content is intended for healthcare professionals. #BreastCancer #Oncology #MedicalEducation #AccrediMix
0
0
0
@Medi_Mix
MediMix
5 days
๐Ÿ”— #AccrediMix #Oncology #LungCancer #MedicalEducation #ADCs Register at today! With the educational support of Daiichi Sankyo and AstraZeneca *This educational content is intended for healthcare professionals.
0
0
0
@Medi_Mix
MediMix
5 days
0
0
0
@Medi_Mix
MediMix
9 days
0
0
0
@Medi_Mix
MediMix
11 days
Watch now! ๐Ÿ‘€#MediMix #GastricCancer #Immunotherapy
0
0
0
@Medi_Mix
MediMix
11 days
0
0
0